
Top vaccine official’s ouster sends biotech stocks tumbling
“Peter Marks has been pushed out,” Cantor analyst Josh Schimmer wrote in a note that summed up the feeling of many observers. “OMG. Not good.” The departure of Marks from the FDA’s Center for Biologics Evaluation and Research raised red flags for industry …